| Product Code: ETC13144441 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Genome Sequencing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Genome Sequencing Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Genome Sequencing Market Revenues & Volume, 2021 & 2031F |
3.3 North America Genome Sequencing Market - Industry Life Cycle |
3.4 North America Genome Sequencing Market - Porter's Five Forces |
3.5 North America Genome Sequencing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Genome Sequencing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 North America Genome Sequencing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 North America Genome Sequencing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 North America Genome Sequencing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 North America Genome Sequencing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Genome Sequencing Market Trends |
6 North America Genome Sequencing Market, 2021 - 2031 |
6.1 North America Genome Sequencing Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Genome Sequencing Market, Revenues & Volume, By Consumables, 2021 - 2031 |
6.1.3 North America Genome Sequencing Market, Revenues & Volume, By Systems and Software, 2021 - 2031 |
6.1.4 North America Genome Sequencing Market, Revenues & Volume, By Services, 2021 - 2031 |
6.2 North America Genome Sequencing Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Genome Sequencing Market, Revenues & Volume, By PCR, 2021 - 2031 |
6.2.3 North America Genome Sequencing Market, Revenues & Volume, By Sequencing, 2021 - 2031 |
6.2.4 North America Genome Sequencing Market, Revenues & Volume, By Microarray, 2021 - 2031 |
6.2.5 North America Genome Sequencing Market, Revenues & Volume, By Nucleic Acid Extraction, 2021 - 2031 |
6.2.6 North America Genome Sequencing Market, Revenues & Volume, By Purification, 2021 - 2031 |
6.2.7 North America Genome Sequencing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 North America Genome Sequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Genome Sequencing Market, Revenues & Volume, By Diagnostics, 2021 - 2031 |
6.3.3 North America Genome Sequencing Market, Revenues & Volume, By Drug Discovery and Development, 2021 - 2031 |
6.3.4 North America Genome Sequencing Market, Revenues & Volume, By Precision Medicine, 2021 - 2031 |
6.3.5 North America Genome Sequencing Market, Revenues & Volume, By Agriculture and Animal Research, 2021 - 2031 |
6.3.6 North America Genome Sequencing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 North America Genome Sequencing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.2 North America Genome Sequencing Market, Revenues & Volume, By Research Centers, 2021 - 2031 |
6.4.3 North America Genome Sequencing Market, Revenues & Volume, By Academic and Government Institutes, 2021 - 2031 |
6.4.4 North America Genome Sequencing Market, Revenues & Volume, By Hospitals & Clinics, 2021 - 2031 |
6.4.5 North America Genome Sequencing Market, Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021 - 2031 |
6.4.6 North America Genome Sequencing Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Genome Sequencing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Genome Sequencing Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.1 United States (US) Genome Sequencing Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.2 Canada Genome Sequencing Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.3 Rest of North America Genome Sequencing Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3 North America Genome Sequencing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
7.3.1 United States (US) Genome Sequencing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.2 Canada Genome Sequencing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.3 Rest of North America Genome Sequencing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4 North America Genome Sequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.1 United States (US) Genome Sequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.2 Canada Genome Sequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.3 Rest of North America Genome Sequencing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Genome Sequencing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United States (US) Genome Sequencing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Canada Genome Sequencing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 Rest of North America Genome Sequencing Market, Revenues & Volume, By End User, 2021 - 2031 |
8 North America Genome Sequencing Market Key Performance Indicators |
9 North America Genome Sequencing Market - Export/Import By Countries Assessment |
10 North America Genome Sequencing Market - Opportunity Assessment |
10.1 North America Genome Sequencing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Genome Sequencing Market Opportunity Assessment, By Product, 2021 & 2031F |
10.3 North America Genome Sequencing Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.4 North America Genome Sequencing Market Opportunity Assessment, By Application, 2021 & 2031F |
10.5 North America Genome Sequencing Market Opportunity Assessment, By End User, 2021 & 2031F |
11 North America Genome Sequencing Market - Competitive Landscape |
11.1 North America Genome Sequencing Market Revenue Share, By Companies, 2022 |
11.2 North America Genome Sequencing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here